Abstract
Timeliness is key to influencing the utility of evaluation and research findings and has given rise to a range of rapid evaluation and appraisal approaches. However, issues in the design, implementation and transparency in their reporting has led to concerns around their rigour and validity. To address this, we have developed the Standards for Rapid Evaluation and Appraisal Methods (STREAM). We followed a four-stage consensus process, starting with a (1) steering group consultation; (2) three-stage e-Delphi study; (3) stakeholder consensus workshop; and (4) piloting exercise. The stakeholders invited to participate in the consensus process had experience in conducting, being part of, or commissioning rapid evaluations or appraisals. As a result, 38 standards were developed with the purpose of guiding the design and implementation of rapid evaluations and appraisals and supporting the reporting of methods used. We suggest strengthening STREAM by testing it in alternative contexts to assess its generalisability.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by a UKRI MRC Better Methods Better Research grant (MR/W020769/1)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was received from the UCL Research Ethics Committee under the project ID: 23555/001.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.